Dr Cuff presents his research at the 2020 American Academy of Orthopaedic Surgeons Meeting
The 2020 annual meeting of the American Academy of Orthopaedic Surgeons was held virtually due to the COVID-19 pandemic. Orthopaedic surgeons from around the world presented their research via a digital platform. Dr. Cuff had two separate studies that were accepted for presentation at this esteemed meeting. Dr. Cuff presented his research examining the use of the reverse shoulder prosthesis for severe glenoid bone loss cases, and also presented his research demonstrating the reduction of blood loss using tranexamic acid in the setting of the surgical management of proximal humeral fractures.
Dr Cuff has a paper on the use of tranexamic acid for proximal humeral fractures accepted for publication in the Journal of Shoulder and Elbow Surgery
Dr Cuff performed a prospective randomized study evaluating the use of tranexamic acid in the treatment of patients undergoing surgery for a proximal humeral fracture. This study evaluated patients treated with either open reduction internal fixation, or patients with more severe fractures requiring a reverse shoulder replacement to treat their shoulder injury. Those patients given one pre-operative dose of tranexamic acid (a medicine that can reduce bleeding) had a statistically significant reduction in blood loss for their procedure compared to those patients who did not receive a dose of this medication to minimize blood loss. No adverse effects were noted with the use of tranexamic acid to reduce bleeding. This data has been accepted for publication in an upcoming edition of the Journal of Shoulder and Elbow Surgery.